Kelly M. Chin

Palliative Medicine

888 Old Country Road
Plainview, NY 11803

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 96 publications

Combined Post- and Precapillary Pulmonary Hypertension in Patients With Advanced Heart Failure.

Combined Post- and Precapillary Pulmonary Hypertension in Patients With Advanced Heart Failure.

Journal: Circulation. Heart failure

Published: August 18, 2026

Stepping Into a New Era: Sotatercept for the Treatment of Combined Precapillary and Postcapillary Pulmonary Hypertension From Heart Failure With Preserved Ejection Fraction.

Stepping Into a New Era: Sotatercept for the Treatment of Combined Precapillary and Postcapillary Pulmonary Hypertension From Heart Failure With Preserved Ejection Fraction.

Journal: Circulation

Published: May 11, 2026

Stepping Into a New Era: Sotatercept for the Treatment of Combined Precapillary and Postcapillary Pulmonary Hypertension From Heart Failure With Preserved Ejection Fraction.

Stepping Into a New Era: Sotatercept for the Treatment of Combined Precapillary and Postcapillary Pulmonary Hypertension From Heart Failure With Preserved Ejection Fraction.

Journal: Circulation

Published: March 29, 2026

Real-World Experience with Selexipag in Patients with Pulmonary Arterial Hypertension: Treatment Patterns and Outcomes across Baseline Risk Strata (SPHERE and EXPOSURE Studies).

Real-World Experience with Selexipag in Patients with Pulmonary Arterial Hypertension: Treatment Patterns and Outcomes across Baseline Risk Strata (SPHERE and EXPOSURE Studies).

Journal: Drugs - real world outcomes

Published: December 11, 2025

Biological Sex Differences in the US-CTEPH-R.

Biological Sex Differences in the US-CTEPH-R.

Journal: Annals of the American Thoracic Society

Published: November 24, 2025

Long-Term Treatment with Single-Tablet Combination of Macitentan and Tadalafil in Pulmonary Arterial Hypertension: Results from A DUE and Its Open-Label Period.

Long-Term Treatment with Single-Tablet Combination of Macitentan and Tadalafil in Pulmonary Arterial Hypertension: Results from A DUE and Its Open-Label Period.

Journal: Advances in therapy

Published: November 11, 2025

Preferences for pulmonary arterial hypertension (PAH) medications: plain language summary on insights from interviews with patients and doctors in the A DUE phase 3 clinical study.

Preferences for pulmonary arterial hypertension (PAH) medications: plain language summary on insights from interviews with patients and doctors in the A DUE phase 3 clinical study.

Journal: Future cardiology

Published: November 04, 2025

How to Care for the Patient With Methamphetamine-Associated Pulmonary Arterial Hypertension.

How to Care for the Patient With Methamphetamine-Associated Pulmonary Arterial Hypertension.

Journal: Chest

Published: October 10, 2025

Performance of Guideline-Recommended Approaches to Echocardiographic Investigation for Pulmonary Hypertension: Analysis of the CIPHER Study.

Performance of Guideline-Recommended Approaches to Echocardiographic Investigation for Pulmonary Hypertension: Analysis of the CIPHER Study.

Journal: Pulmonary circulation

Published: September 02, 2025

Characteristics, Treatment Patterns and Outcomes of Patients with Pulmonary Arterial Hypertension by Race and Ethnicity Using Real-World Data from the Combined OPUS/OrPHeUS Studies.

Characteristics, Treatment Patterns and Outcomes of Patients with Pulmonary Arterial Hypertension by Race and Ethnicity Using Real-World Data from the Combined OPUS/OrPHeUS Studies.

Journal: Advances in therapy

Published: August 14, 2025

Circulating Biomarker Results From a Phase 2 Study of Seralutinib in Pulmonary Arterial Hypertension.

Circulating Biomarker Results From a Phase 2 Study of Seralutinib in Pulmonary Arterial Hypertension.

Journal: American journal of respiratory and critical care medicine

Published: August 08, 2025

Circulating biomarker results from a phase 2 study of seralutinib in pulmonary arterial hypertension.

Circulating biomarker results from a phase 2 study of seralutinib in pulmonary arterial hypertension.

Journal: American journal of respiratory and critical care medicine

Published: August 08, 2025

Showing 1-12 of 96

Last Updated: 09/26/2026